Lam Research Corporation $LRCX Shares Bought by Sava Infond d.o.o.

Sava Infond d.o.o. raised its position in Lam Research Corporation (NASDAQ:LRCXFree Report) by 5.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 79,650 shares of the semiconductor company’s stock after buying an additional 4,400 shares during the quarter. Lam Research makes up approximately 1.5% of Sava Infond d.o.o.’s portfolio, making the stock its 16th biggest position. Sava Infond d.o.o.’s holdings in Lam Research were worth $10,665,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Howard Hughes Medical Institute acquired a new stake in Lam Research during the 2nd quarter worth $27,000. Sound Income Strategies LLC purchased a new stake in shares of Lam Research in the third quarter valued at about $41,000. Tripletail Wealth Management LLC acquired a new stake in shares of Lam Research during the third quarter worth about $44,000. Strategic Wealth Investment Group LLC purchased a new position in shares of Lam Research during the second quarter worth about $29,000. Finally, Delos Wealth Advisors LLC acquired a new position in Lam Research in the 2nd quarter valued at about $30,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

Lam Research Price Performance

Lam Research stock opened at $244.92 on Friday. The company has a market cap of $305.85 billion, a P/E ratio of 50.19, a price-to-earnings-growth ratio of 2.55 and a beta of 1.78. Lam Research Corporation has a one year low of $56.32 and a one year high of $251.87. The business has a fifty day moving average of $209.11 and a two-hundred day moving average of $159.86. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.61 and a current ratio of 2.26.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter last year, the firm posted $0.91 EPS. The business’s revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be issued a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. Lam Research’s dividend payout ratio (DPR) is 21.31%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on LRCX. Jefferies Financial Group reaffirmed a “buy” rating and set a $200.00 price objective (up from $175.00) on shares of Lam Research in a research report on Monday, December 15th. Deutsche Bank Aktiengesellschaft upped their price target on Lam Research from $260.00 to $290.00 and gave the stock a “buy” rating in a research note on Thursday, January 29th. KeyCorp reiterated a “sector weight” rating on shares of Lam Research in a research report on Thursday, January 29th. Susquehanna set a $325.00 price objective on shares of Lam Research and gave the stock a “positive” rating in a research report on Thursday, January 29th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Lam Research from $165.00 to $300.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Lam Research currently has an average rating of “Moderate Buy” and an average price target of $244.88.

View Our Latest Research Report on Lam Research

Insider Activity

In other news, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares of the company’s stock, valued at $57,235,848. The trade was a 12.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.31% of the company’s stock.

About Lam Research

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

See Also

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.